These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1762051)

  • 1. [Monoamine oxidase inhibitory effects of pentanthrene type heterocyclic compounds].
    Noda A; Noda H; Imamura T; Ono Y; Morita M; Kai M; Mine S; Goto S
    Yakugaku Zasshi; 1991 Sep; 111(9):499-503. PubMed ID: 1762051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and selective human monoamine oxidase B inhibition of heterocyclic hybrids based on hydrazine and thiazole scaffolds.
    Carradori S; D'Ascenzio M; De Monte C; Secci D; Yáñez M
    Arch Pharm (Weinheim); 2013 Jan; 346(1):17-22. PubMed ID: 23065686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single Heterocyclic Compounds as Monoamine Oxidase Inhibitors: From Past to Present.
    Wu SM; Qiu XY; Liu SJ; Sun J
    Mini Rev Med Chem; 2020; 20(10):908-920. PubMed ID: 32116191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase inhibitory activities of heterocyclic chalcones.
    Minders C; Petzer JP; Petzer A; Lourens AC
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5270-6. PubMed ID: 26432037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibitors of monoamine oxidase (MAO). 5. 1-Substituted phenoxathiin inhibitors containing no nitrogen that inhibit MAO A by binding it to a hydrophobic site.
    Harfenist M; McGee DP; Reeves MD; White HL
    J Med Chem; 1998 Jun; 41(12):2118-25. PubMed ID: 9622553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of dimethylnitrosamine metabolism by some heterocyclic compounds and by substrates and inhibitors of monoamine oxidase in the rat.
    Phillips JC; Bex C; Lake BG; Cottrell RC; Gangolli SD
    Cancer Res; 1982 Sep; 42(9):3761-5. PubMed ID: 7105041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
    Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [SENSITIVITY OF LIVER MONOAMINE OXIDASE IN THE LAMPREY LAMPETRA FLUVIATILIS TO SOME TRICYCLIC COMPOUNDS].
    Basova LN; Basova NE; Suvorov AA; Yagodina OV
    Zh Evol Biokhim Fiziol; 2015; 51(3):163-9. PubMed ID: 26281218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors.
    Altintop MD; Sever B; Osmaniye D; Sağlık BN; Özdemir A
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800082. PubMed ID: 29963739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of lazabemide derivatives as inhibitors of monoamine oxidase.
    Zhou S; Chen G; Huang G
    Bioorg Med Chem; 2018 Sep; 26(17):4863-4870. PubMed ID: 30143367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
    Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.
    Hammuda A; Shalaby R; Rovida S; Edmondson DE; Binda C; Khalil A
    Eur J Med Chem; 2016 May; 114():162-9. PubMed ID: 26974383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B.
    Kalir A; Sabbagh A; Youdim MB
    Br J Pharmacol; 1981 May; 73(1):55-64. PubMed ID: 7284698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase.
    Nel MS; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Chem; 2016 Dec; 69():20-28. PubMed ID: 27662218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of rat liver mitochondrial monoamine oxidase by hydrazine-thiazole derivatives: structure-activity relationships.
    Raciti G; Mazzone P; Raudino A; Mazzone G; Cambria A
    Bioorg Med Chem; 1995 Nov; 3(11):1485-91. PubMed ID: 8634828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Benzylidene-1-indanone derivatives as inhibitors of monoamine oxidase.
    Nel MS; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Med Chem Lett; 2016 Oct; 26(19):4599-4605. PubMed ID: 27578245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of monoamine oxidase by selected phenylalkylcaffeine analogues.
    Petzer A; Grobler P; Bergh JJ; Petzer JP
    J Pharm Pharmacol; 2014 May; 66(5):677-87. PubMed ID: 24313346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of monoamine oxidase by 8-[(phenylethyl)sulfanyl]caffeine analogues.
    Mostert S; Mentz W; Petzer A; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2012 Dec; 20(24):7040-50. PubMed ID: 23122934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship of a new series of tricyclic monoamine oxidase inhibitors of pentanthrene type.
    Kai M; Noda A; Noda H; Goto S
    Chem Pharm Bull (Tokyo); 1988 Sep; 36(9):3604-8. PubMed ID: 3240550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.